Clin2
NCT06183307Possibly a fitRecruiting

Nattokinase for heart health in people with high cholesterol

Cardiovascular DiseasesDyslipidemiasInflammation

Part of Heart & circulation, Hormones & metabolism clinical trials.

This trial tests whether nattokinase, a natural enzyme, can reduce inflammation and improve heart health in people with high cholesterol or high triglycerides. If you have elevated LDL or triglycerides, you may be eligible even if you are already taking cholesterol medication.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
48 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years or older
  • You have high LDL cholesterol (over 160 mg/dL) and/or high triglycerides (over 150 mg/dL)
  • You may also be included if you have low HDL cholesterol (under 40 for men, under 50 for women), even if you are already on cholesterol medication
  • You cannot have diabetes, autoimmune disease, active infection, cancer, or AIDS
  • You cannot be pregnant
  • You cannot be taking blood thinners, antibiotics, or certain catabolic drugs, and you cannot be allergic to corn or soy starch

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07331103Recruiting
Can a special diet reduce inflammation for heart health?

This study tests whether a special diet can reduce inflammation and improve heart health in people over 55 who are at increased risk for heart disease but have not yet had a heart attack or stroke.

Avellino, AV
NCT07491172Recruiting· Phase 1
Trial of CTX310 for stubborn high cholesterol and fats

This trial tests a new medicine, CTX310, for people with persistently high levels of fats (triglycerides) and cholesterol that have not improved with standard treatments. It aims to see if the drug is safe and tolerable.

Hialeah, Florida
NCT07229521Recruiting
Nattokinase for heart, gut, sleep, and brain health in metabolic syndrome with sleep issues

This study tests whether a supplement called nattokinase can improve heart health, sleep, thinking, and gut bacteria in people with metabolic syndrome and mild-to-moderate sleep apnea. If you have a larger waist, blood pressure or blood sugar issues, or imbalanced cholesterol, and have been diagnosed with mild or moderate sleep apnea, you may be eligible.

Taipei
NCT06910111Not yet recruiting
Capturing heart health with a fat-blocking supplement

This study tests a natural supplement (polyglucosamine) that may help reduce fat absorption, aiming to prevent heart disease and stroke. It is for people with high blood pressure, diabetes, or high cholesterol who also have early signs of artery thickening.

Pisa, Tuscany
NCT06494488Recruiting· Early Phase 1
Testing how omega-3s affect heart health and blood clotting

This study tests whether two types of omega-3s (EPA and DHA) help improve HDL (good cholesterol) and reduce blood clot risk in people with high triglycerides and low HDL cholesterol.

Providence, Rhode Island
NCT07515573Not yet recruiting
Heart Health Supplement Study for People at Low Risk

This study tests whether a supplement called Cardiol Forte can help improve cholesterol and blood sugar levels in people who have slightly elevated cholesterol but are at low risk for heart disease. Researchers want to see if this supplement can naturally help manage cholesterol without prescription drugs.

Bologna, BO

Hear when a new Cardiovascular Diseases trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.